Monday, 3 May 2021
Natco gets CDSCO nod for emergency use of Baricitinib tablets for COVID-19 treatment
Baricitinib in combination with Remdesivir, is used for treatment of COVID-19 positive patients, the Natco Pharma said
from The Hindu - Business
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment